- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- monomer
- Ligands
- 1 x AGS: PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 15 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 6 residues within 4Å:- Chain A: Y.222, Q.347, S.349, K.420, R.426
- Ligands: EDO.4
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.420, A:R.426
EDO.4: 8 residues within 4Å:- Chain A: E.250, R.320, Q.321, Q.347, S.348, S.349
- Ligands: EDO.3, PEG.20
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.349
- Water bridges: A:E.250
EDO.5: 8 residues within 4Å:- Chain A: Y.256, C.257, P.258, H.324, Y.325, G.326, A.327, P.328
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.326
- Water bridges: A:C.257
EDO.6: 4 residues within 4Å:- Chain A: D.90, Q.94, H.293, N.315
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.90, A:H.293
EDO.7: 8 residues within 4Å:- Chain A: Y.280, H.293, F.310, G.311, M.312, I.314
- Ligands: EDO.13, MLT.15
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.280, A:G.311
- Water bridges: A:R.289, A:M.312
EDO.8: 8 residues within 4Å:- Chain A: G.60, R.218, N.220, G.339, A.341, G.342, R.343
- Ligands: EDO.23
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.220, A:N.220, A:G.339
EDO.9: 5 residues within 4Å:- Chain A: A.190, E.332, S.333, Q.336, K.378
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.332, A:K.378
- Water bridges: A:E.337
EDO.11: 5 residues within 4Å:- Chain A: Y.29, F.30, Q.68, L.95, S.98
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.68, A:S.98, A:S.98
EDO.12: 6 residues within 4Å:- Chain A: P.83, T.128, P.129, E.130, S.169, K.172
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.130
EDO.13: 5 residues within 4Å:- Chain A: L.84, L.87, A.309, M.312
- Ligands: EDO.7
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:A.309
- Water bridges: A:S.86, A:R.289
EDO.17: 2 residues within 4Å:- Chain A: K.118, Q.141
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.118, A:Q.141
EDO.18: 5 residues within 4Å:- Chain A: R.363, L.379, M.382, A.383, E.386
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.363, A:R.363
EDO.19: 1 residues within 4Å:- Chain A: K.121
No protein-ligand interaction detected (PLIP)EDO.22: 4 residues within 4Å:- Chain A: Y.73, V.74, G.75
- Ligands: PEG.16
No protein-ligand interaction detected (PLIP)EDO.23: 5 residues within 4Å:- Chain A: G.342, R.343, D.344, G.345
- Ligands: EDO.8
No protein-ligand interaction detected (PLIP)- 1 x 01: ~{N}-[1-[(4-fluorophenyl)methyl]-7-methyl-indazol-3-yl]propanamide
01.10: 18 residues within 4Å:- Chain A: V.56, M.57, A.58, A.190, A.192, C.213, T.214, G.215, M.331, E.332, Y.335, Q.336, Y.377, M.381, I.399, H.402, F.403
- Ligands: 02.14
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:V.56, A:A.58, A:E.332, A:E.332, A:Y.335, A:Y.335, A:H.402, A:F.403, A:F.403
- Hydrogen bonds: A:G.215, A:H.402
- pi-Stacking: A:H.402, A:F.403
- 1 x 02: ~{N}-[1-[(4-fluorophenyl)methyl]-7-methyl-indazol-3-yl]prop-2-enamide
02.14: 20 residues within 4Å:- Chain A: V.56, M.57, A.58, A.190, T.191, A.192, C.213, T.214, G.215, M.331, E.332, Y.335, Q.336, Y.377, M.381, I.399, H.402, F.403, E.404
- Ligands: 01.10
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.56, A:E.332, A:E.332, A:Y.335, A:H.402, A:F.403
- Hydrogen bonds: A:G.215
- pi-Stacking: A:H.402, A:F.403
- 1 x MLT: D-MALATE(Non-covalent)
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.16: 7 residues within 4Å:- Chain A: Y.29, V.72, G.75, N.99, P.101, R.123
- Ligands: EDO.22
No protein-ligand interaction detected (PLIP)PEG.20: 5 residues within 4Å:- Chain A: E.250, R.320, L.346, Q.347
- Ligands: EDO.4
No protein-ligand interaction detected (PLIP)PEG.21: 5 residues within 4Å:- Chain A: L.47, R.50, V.74, K.76, T.149
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.76
PEG.24: 6 residues within 4Å:- Chain A: M.28, Y.29, M.97, S.98, N.99
- Ligands: DMS.25
No protein-ligand interaction detected (PLIP)PEG.26: 2 residues within 4Å:- Chain A: R.298, E.300
No protein-ligand interaction detected (PLIP)- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, G.M.T. et al., AI-assisted delivery of novel covalent WRN inhibitors from a non-covalent fragment screen. Bioorg.Med.Chem.Lett. (2025)


- Release Date
- 2025-10-22
- Peptides
- Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- monomer
- Ligands
- 1 x AGS: PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 15 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x 01: ~{N}-[1-[(4-fluorophenyl)methyl]-7-methyl-indazol-3-yl]propanamide
- 1 x 02: ~{N}-[1-[(4-fluorophenyl)methyl]-7-methyl-indazol-3-yl]prop-2-enamide
- 1 x MLT: D-MALATE(Non-covalent)
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, G.M.T. et al., AI-assisted delivery of novel covalent WRN inhibitors from a non-covalent fragment screen. Bioorg.Med.Chem.Lett. (2025)


- Release Date
- 2025-10-22
- Peptides
- Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A